Alphabet was among the investors in the latest round for life sciences spinoff Verily, which has now disclosed $2.5bn in funding across three rounds.
Verily, a US-headquartered developer of data-focused life sciences technology, received $700m in funding yesterday from investors including its parent company, internet and technology conglomerate Alphabet.
The company said the funding was provided by its current investors and named private equity firm Silver Lake, Singaporean state-owned investment firm Temasek and pension fund manager Ontario Teachers’ Pension Plan alongside Alphabet.
Launched in 2015 after being incubated within Alphabet’s Google X division, Verily is working on hardware and software products in partnership with…
